Skip to main content

Mometasone News

Related terms: Mometasone Topical, Mometasone Nasal

FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use

DUBLIN, March 17, 2022 /PRNewswire/ – Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the...

FDA Approves Ryaltris (mometasone and olopatadine) Nasal Spray for Seasonal Allergic Rhinitis

Mumbai (Maharashtra) [India], January 14, 2022 (ANI/PRNewswire) – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned...

Intersect ENT Announces FDA Approval of Sinuva (mometasone furoate) Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps

MENLO PARK, Calif.--(BUSINESS WIRE)--Dec. 11, 2017-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance

Mometasone patient information at Drugs.com